94 related articles for article (PubMed ID: 3261049)
1. Recombinant interleukin-2 (rIL-2) improves immune response and host resistance to septic challenge in thermally injured mice.
Gough DB; Moss NM; Jordan A; Grbic JT; Rodrick ML; Mannick JA
Surgery; 1988 Aug; 104(2):292-300. PubMed ID: 3261049
[TBL] [Abstract][Full Text] [Related]
2. Temporal correlation of impaired immune response after thermal injury with susceptibility to infection in a murine model.
Moss NM; Gough DB; Jordan AL; Grbic JT; Wood JJ; Rodrick ML; Mannick JA
Surgery; 1988 Nov; 104(5):882-7. PubMed ID: 3263707
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-4 treatment restores cellular immunity after ethanol exposure and burn injury.
Messingham KA; Heinrich SA; Schilling EM; Kovacs EJ
Alcohol Clin Exp Res; 2002 Apr; 26(4):519-26. PubMed ID: 11981129
[TBL] [Abstract][Full Text] [Related]
4. Lymphokine activated killer cells enhance IL-2 prevention of sepsis-related death in a murine model of thermal injury.
Mendez MV; Molloy RG; O'Riordain DS; Holzheimer RG; Nestor MS; Obando A; Saporoschetz I; Schoof DD; Mannick JA; Rodrick ML
J Surg Res; 1993 Jun; 54(6):565-70. PubMed ID: 8412066
[TBL] [Abstract][Full Text] [Related]
5. [Effects of ethyl pyruvate on cell-mediated immune function in rats with delayed resuscitation after burn injury].
Dong YQ; Yao YM; Wei P; Liu H; Dong N; Yu Y; Sheng ZY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Jan; 17(1):12-5. PubMed ID: 15636704
[TBL] [Abstract][Full Text] [Related]
6. Anti-interleukin-6 antibody treatment restores cell-mediated immune function in mice with acute ethanol exposure before burn trauma.
Fontanilla CV; Faunce DE; Gregory MS; Messingham KA; Durbin EA; Duffner LA; Kovacs EJ
Alcohol Clin Exp Res; 2000 Sep; 24(9):1392-9. PubMed ID: 11003205
[TBL] [Abstract][Full Text] [Related]
7. Gender difference in cell-mediated immunity after thermal injury is mediated, in part, by elevated levels of interleukin-6.
Gregory MS; Faunce DE; Duffner LA; Kovacs EJ
J Leukoc Biol; 2000 Mar; 67(3):319-26. PubMed ID: 10733091
[TBL] [Abstract][Full Text] [Related]
8. Interaction between the innate and adaptive immune systems is required to survive sepsis and control inflammation after injury.
Shelley O; Murphy T; Paterson H; Mannick JA; Lederer JA
Shock; 2003 Aug; 20(2):123-9. PubMed ID: 12865655
[TBL] [Abstract][Full Text] [Related]
9. Multiple system organ failure may be influenced by macrophage hypoactivation as well as hyperactivation--importance of the double challenge.
Holzheimer RG; Molloy R; Mendez MV; O'Riordain D; Curley P; Nestor M; Collins K; Saproschetz I; Mannick JA; Rodrick ML
Eur J Surg; 1995 Nov; 161(11):795-803. PubMed ID: 8749211
[TBL] [Abstract][Full Text] [Related]
10. Insights into the role of gammadelta T lymphocytes in the immunopathogenic response to thermal injury.
Schwacha MG; Ayala A; Chaudry IH
J Leukoc Biol; 2000 May; 67(5):644-50. PubMed ID: 10811004
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent effect of ethanol on hepatic oxidative stress and interleukin-6 production after burn injury in the mouse.
Colantoni A; Duffner LA; De Maria N; Fontanilla CV; Messingham KA; Van Thiel DH; Kovacs EJ
Alcohol Clin Exp Res; 2000 Sep; 24(9):1443-8. PubMed ID: 11003212
[TBL] [Abstract][Full Text] [Related]
12. Effect of rIFN-gamma and IL-2 treatments in mouse and nude rat infections with Toxoplasma gondii.
Benedetto N; Auriault C; Darcy F; Lando D; Watier H; Capron A
Eur Cytokine Netw; 1991; 2(2):107-14. PubMed ID: 1813013
[TBL] [Abstract][Full Text] [Related]
13. [Strategy of cancer treatment using human recombinant interleukin 2 and lymphokine activated killer cells].
Saijo N; Ozaki A; Ishihara J; Sakurai M; Sasaki Y; Takahashi H; Sano T; Hoshi A
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1290-7. PubMed ID: 3488026
[TBL] [Abstract][Full Text] [Related]
14. Phase I trial of recombinant interleukin-2 and cyclophosphamide: augmentation of cellular immunity and T-cell mitogenic response with long-term administration of rIL-2.
Kolitz JE; Wong GY; Welte K; Merluzzi VJ; Engert A; Bialas T; Polivka A; Bradley EC; Konrad M; Gnecco C
J Biol Response Mod; 1988 Oct; 7(5):457-72. PubMed ID: 3263471
[TBL] [Abstract][Full Text] [Related]
15. Burn-induced immunosuppression: attenuated T cell signaling independent of IFN-gamma- and nitric oxide-mediated pathways.
Duan X; Yarmush D; Leeder A; Yarmush ML; Mitchell RN
J Leukoc Biol; 2008 Feb; 83(2):305-13. PubMed ID: 18024716
[TBL] [Abstract][Full Text] [Related]
16. [The effect of intraperitoneal administration of OK-432 with recombinant interleukin-2 to patients with peritonitis carcinomatosa of recurrent gynecological cancer and changes in ascitic lymphocyte subsets].
Kanaoka Y; Umesaki N
Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):489-96. PubMed ID: 2056223
[TBL] [Abstract][Full Text] [Related]
17. Opiate analgesics contribute to the development of post-injury immunosuppression.
Alexander M; Daniel T; Chaudry IH; Schwacha MG
J Surg Res; 2005 Nov; 129(1):161-8. PubMed ID: 16139307
[TBL] [Abstract][Full Text] [Related]
18. The success of locoregional, low-dose recombinant interleukin-2 therapy in tumor-bearing mice is dependent on the time of rIL-2 administration.
Everse LA; Bernsen MR; Dullens HF; Den Otter W
J Exp Ther Oncol; 1996 Jul; 1(4):231-6. PubMed ID: 9414409
[TBL] [Abstract][Full Text] [Related]
19. Effect of low dose recombinant interleukin 2 plus indomethacin on mortality after sepsis in a murine burn model.
Horgan PG; Mannick JA; Dubravec DB; Rodrick ML
Br J Surg; 1990 Apr; 77(4):401-4. PubMed ID: 2340389
[TBL] [Abstract][Full Text] [Related]
20. Enhanced cell-mediated protection against fatal Escherichia coli septicemia induced by treatment with recombinant IL-2.
Goronzy J; Weyand C; Quan J; Fathman CG; O'Hanley P
J Immunol; 1989 Feb; 142(4):1134-8. PubMed ID: 2644349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
